![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1598206 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TNFRSF25 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1312747 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TNFRSF25 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19429434 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TNFRSF25 mRNA | CTD | PMID:23019147 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27589474 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1312747 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF25 mRNA | CTD | PMID:15328365 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1598206 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFRSF25 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TNFRSF25 mRNA | CTD | PMID:18762178 | 2,4,6-trinitrobenzenesulfonic acid | increases response to substance | ISO | RGD:1312747 | 6480464 | TNFRSF25 protein results in increased susceptibility to Trinitrobenzenesulfonic Acid | CTD | PMID:20980995 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:1312747 | 6480464 | tetrabromobisphenol A results in decreased expression of TNFRSF25 mRNA | CTD | PMID:25172293 | 3,3'-diindolylmethane | decreases expression | EXP | | 6480464 | 3, 3'-diindolylmethane results in decreased expression of TNFRSF25 mRNA | CTD | PMID:22514694 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:1312747 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of TNFRSF25 mRNA | CTD | PMID:20188158 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1598206 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of TNFRSF25 mRNA | CTD | PMID:30071829 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1312747 | 6480464 | Fenretinide results in decreased expression of TNFRSF25 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1312747 | 6480464 | Decitabine results in increased expression of TNFRSF25 mRNA | CTD | PMID:27915011 | acetamide | increases expression | ISO | RGD:1598206 | 6480464 | acetamide results in increased expression of TNFRSF25 mRNA | CTD | PMID:31881176 | acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of TNFRSF25 mRNA | CTD | PMID:20457246 | aldehydo-D-glucose | decreases expression | ISO | RGD:1312747 | 6480464 | Glucose results in decreased expression of TNFRSF25 mRNA | CTD | PMID:31525975 | amphetamine | decreases expression | ISO | RGD:1598206 | 6480464 | Amphetamine results in decreased expression of TNFRSF25 mRNA | CTD | PMID:30779732 | arsane | multiple interactions | EXP | | 6480464 | [Arsenic co-treated with Fluorides] results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19962721 | arsane | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19962721 | arsenic atom | multiple interactions | EXP | | 6480464 | [Arsenic co-treated with Fluorides] results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19962721 | arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19962721 | arsenous acid | decreases expression | ISO | RGD:1598206 | 6480464 | Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19730151 | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA | CTD | PMID:15761015, PMID:17530438 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzoapyrene results in decreased methylation of TNFRSF25 exon | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19371625 | bisphenol A | increases methylation | ISO | RGD:1598206 | 6480464 | bisphenol A results in increased methylation of TNFRSF25 gene | CTD | PMID:28505145 | bisphenol A | decreases methylation | ISO | RGD:1312747 | 6480464 | bisphenol A results in decreased methylation of TNFRSF25 promoter | CTD | PMID:27312807 | bisphenol A | affects expression | ISO | RGD:1598206 | 6480464 | bisphenol A affects the expression of TNFRSF25 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TNFRSF25 mRNA | CTD | PMID:23019147 | Brevetoxin B | increases expression | EXP | | 6480464 | brevetoxin 2 results in increased expression of TNFRSF25 mRNA | CTD | PMID:20498034 | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of TNFRSF25 mRNA | CTD | PMID:22562489 | capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of TNFRSF25 mRNA | CTD | PMID:19502594 | carbon nanotube | decreases expression | ISO | RGD:1312747 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloroprene | decreases expression | ISO | RGD:1598206 | 6480464 | Chloroprene results in decreased expression of TNFRSF25 mRNA | CTD | PMID:23125180 | choline | multiple interactions | ISO | RGD:1312747 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFRSF25 gene | CTD | PMID:20938992 | chromium(6+) | increases expression | EXP | | 6480464 | chromium hexavalent ion results in increased expression of TNFRSF25 mRNA | CTD | PMID:17382205 | cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [jinfukang results in increased expression of TNFRSF25 mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of TNFRSF25 mRNA] | CTD | PMID:27392435 | cocaine | affects expression | ISO | RGD:1312747 | 6480464 | Cocaine affects the expression of TNFRSF25 mRNA | CTD | PMID:15681117 | cocaine | multiple interactions | ISO | RGD:1312747 | 6480464 | EHMT2 inhibits the reaction [Cocaine results in increased expression of TNFRSF25 mRNA] | CTD | PMID:20056891 | cocaine | increases expression | ISO | RGD:1312747 | 6480464 | Cocaine results in increased expression of TNFRSF25 mRNA | CTD | PMID:20056891 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of TNFRSF25 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of TNFRSF25 mRNA | CTD | PMID:25562108 | D-glucose | decreases expression | ISO | RGD:1312747 | 6480464 | Glucose results in decreased expression of TNFRSF25 mRNA | CTD | PMID:31525975 | diarsenic trioxide | decreases expression | ISO | RGD:1598206 | 6480464 | Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19730151 | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA | CTD | PMID:15761015, PMID:17530438 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of TNFRSF25 gene | CTD | PMID:22964155 | diethylstilbestrol | increases expression | ISO | RGD:1312747 | 6480464 | Diethylstilbestrol results in increased expression of TNFRSF25 mRNA | CTD | PMID:16510352 | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19371625 | dioscin | increases expression | EXP | | 6480464 | dioscin results in increased expression of TNFRSF25 mRNA | CTD | PMID:29990575 | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of TNFRSF25 mRNA | CTD | PMID:16705456 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TNFRSF25 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of TNFRSF25 mRNA | CTD | PMID:16705698 | folic acid | multiple interactions | ISO | RGD:1312747 | 6480464 | [1 more ... | CTD | PMID:20938992, PMID:22206623 | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of TNFRSF25 promoter | CTD | PMID:22847954 | furan | decreases expression | ISO | RGD:1598206 | 6480464 | furan results in decreased expression of TNFRSF25 mRNA | CTD | PMID:25539665 | furosemide | affects expression | ISO | RGD:1598206 | 6480464 | Furosemide affects the expression of TNFRSF25 mRNA | CTD | PMID:17497460 | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19371625 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of TNFRSF25 mRNA | CTD | PMID:23019147 | glucose | decreases expression | ISO | RGD:1312747 | 6480464 | Glucose results in decreased expression of TNFRSF25 mRNA | CTD | PMID:31525975 | hesperidin | increases expression | EXP | | 6480464 | Hesperidin results in increased expression of TNFRSF25 mRNA | CTD | PMID:24633329 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of TNFRSF25 mRNA | CTD | PMID:20044591 | hydroquinone | decreases expression | EXP | | 6480464 | hydroquinone results in decreased expression of TNFRSF25 mRNA | CTD | PMID:15452088 | L-methionine | multiple interactions | ISO | RGD:1312747 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFRSF25 gene | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:31935363 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of TNFRSF25 protein | CTD | PMID:31935363 | manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of TNFRSF25 mRNA | CTD | PMID:17175027 | manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of TNFRSF25 mRNA | CTD | PMID:17175027 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of TNFRSF25 mRNA | CTD | PMID:17175027 | melittin | increases expression | EXP | | 6480464 | Melitten results in increased expression of TNFRSF25 mRNA | CTD | PMID:22027265 | melittin | multiple interactions | EXP | | 6480464 | TNFRSF25 protein affects the reaction [Melitten results in decreased phosphorylation of STAT3 protein] | CTD | PMID:22027265 | melittin | affects response to substance | EXP | | 6480464 | TNFRSF25 protein affects the susceptibility to Melitten | CTD | PMID:22027265 | metformin | multiple interactions | EXP | | 6480464 | [Paclitaxel co-treated with Metformin] results in increased expression of TNFRSF25 mRNA | CTD | PMID:29309887 | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of TNFRSF25 mRNA | CTD | PMID:21678067 | methylseleninic acid | increases expression | EXP | | 6480464 | methylselenic acid results in increased expression of TNFRSF25 mRNA | CTD | PMID:11830524 | microcystin RR | decreases expression | EXP | | 6480464 | microcystin RR results in decreased expression of TNFRSF25 protein | CTD | PMID:19111056 | morin | increases expression | EXP | | 6480464 | morin results in increased expression of TNFRSF25 mRNA | CTD | PMID:28689916 | N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | EXP | | 6480464 | Methylnitronitrosoguanidine results in increased expression of TNFRSF25 mRNA | CTD | PMID:12634122 | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of TNFRSF25 mRNA | CTD | PMID:17382205 | p-menthan-3-ol | decreases expression | EXP | | 6480464 | Menthol results in decreased expression of TNFRSF25 mRNA | CTD | PMID:26760959 | paclitaxel | multiple interactions | EXP | | 6480464 | [Paclitaxel co-treated with Metformin] results in increased expression of TNFRSF25 mRNA | CTD | PMID:29309887 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of TNFRSF25 mRNA | CTD | PMID:18836921 | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of TNFRSF25 promoter | CTD | PMID:22847954 | phenylarsine oxide | multiple interactions | EXP | | 6480464 | oxophenylarsine promotes the reaction [Viper Venoms results in increased expression of TNFRSF25 protein], Viper Venoms promotes the reaction [oxophenylarsine results in increased expression of TNFRSF25 protein] | CTD | PMID:25417048 | phenylarsine oxide | increases expression | EXP | | 6480464 | oxophenylarsine results in increased expression of TNFRSF25 protein | CTD | PMID:25417048 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromateVI results in increased expression of TNFRSF25 mRNA | CTD | PMID:17382205 | propylparaben | increases expression | EXP | | 6480464 | propylparaben results in increased expression of TNFRSF25 mRNA | CTD | PMID:24481588 | raloxifene | decreases expression | EXP | | 6480464 | Raloxifene Hydrochloride results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19429434 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TNFRSF25 mRNA | CTD | PMID:27188386 | sodium fluoride | increases expression | ISO | RGD:1312747 | 6480464 | Sodium Fluoride results in increased expression of TNFRSF25 mRNA | CTD | PMID:27862939 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of TNFRSF25 mRNA | CTD | PMID:31533062 | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of TNFRSF25 promoter | CTD | PMID:22847954 | tetrachloromethane | multiple interactions | ISO | RGD:1598206 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TNFRSF25 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | RGD:1598206 | 6480464 | Carbon Tetrachloride results in decreased expression of TNFRSF25 mRNA | CTD | PMID:31150632 | thymoquinone | multiple interactions | EXP | | 6480464 | thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein] | CTD | PMID:31935363 | titanium dioxide | decreases expression | ISO | RGD:1312747 | 6480464 | titanium dioxide results in decreased expression of TNFRSF25 mRNA | CTD | PMID:29264374 | trichloroethene | increases methylation | ISO | RGD:1598206 | 6480464 | Trichloroethylene results in increased methylation of TNFRSF25 gene | CTD | PMID:27618143 | trimellitic anhydride | decreases expression | ISO | RGD:1312747 | 6480464 | trimellitic anhydride results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19042947 | trimethyltin | increases expression | ISO | RGD:1312747 | 6480464 | trimethyltin results in increased expression of TNFRSF25 mRNA | CTD | PMID:21435392 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of TNFRSF25 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of TNFRSF25 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TNFRSF25 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of TNFRSF25 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of TNFRSF25 mRNA | CTD | PMID:25979313 | venom | increases expression | EXP | | 6480464 | Viper Venoms results in increased expression of TNFRSF25 protein | CTD | PMID:25417048 | venom | multiple interactions | EXP | | 6480464 | oxophenylarsine promotes the reaction [Viper Venoms results in increased expression of TNFRSF25 protein], Viper Venoms promotes the reaction [oxophenylarsine results in increased expression of TNFRSF25 protein] | CTD | PMID:25417048 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of TNFRSF25 mRNA | CTD | PMID:27188386 | zearalenone | decreases expression | EXP | | 6480464 | Zearalenone results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19371625 | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of TNFRSF25 mRNA | CTD | PMID:19036117 | |